Skip to main content
Clinical Trials/NCT02672514
NCT02672514
Completed
Not Applicable

Does Minimal Extracorporeal Circulation Improve Outcome in Diabetic Patients Undergoing Elective Coronary Bypass Grafting?

Herzzentrum Coswig0 sites104 target enrollmentFebruary 2010

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Acute Kidney Injury
Sponsor
Herzzentrum Coswig
Enrollment
104
Primary Endpoint
Acute Kidney Injury
Status
Completed
Last Updated
9 years ago

Overview

Brief Summary

The aim of this study was to prospectively evaluate MECC compared with conventional extracorporeal circulation of diabetic patients undergoing elective coronary revascularization procedures. The investigators focused on the effects of extracorporeal circulation especially the renal function between both groups.

Detailed Description

Cardiopulmonary bypass (CPB) is known having a negative influence referring to systemic inflammatory reaction after cardiac surgery which can cause acute kidney injury (AKI). Miniaturized extracorporeal circulation (MECC) attempts to reduce the adverse effects of conventional extracorporeal circulation bypass. Finally, AKI after CPB is a significant clinical problem that increasingly complicates the course of hospitalization and clinical outcome.

Registry
clinicaltrials.gov
Start Date
February 2010
End Date
June 2015
Last Updated
9 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Herzzentrum Coswig
Responsible Party
Principal Investigator
Principal Investigator

PD Dr. Hausmann

chief physician

Herzzentrum Coswig

Eligibility Criteria

Inclusion Criteria

  • diabetes mellitus type 2
  • isolated elective coronary revascularization

Exclusion Criteria

  • urgent or emergent Status
  • Re-Operation
  • preexisting reanimation
  • preexisting renal transplantation
  • chronic kidney insufficiency (GFR \< 30 ml/min)
  • renal cell carcinoma
  • renal artery Stenosis
  • heart valve disease (middle- and high-grade)
  • endocarditis
  • infections (HIV, Tbc and all types of Hepatitis)

Outcomes

Primary Outcomes

Acute Kidney Injury

Time Frame: within the first 30 days (plus or minus 3 days) after surgery

Similar Trials